News Sentiment

LUCD sentiment intelligence

Lucid Diagnostics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 64 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 1.08 Week of 19 Jun 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings

79/100 classification confidence.

Company focus 51

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+12.4% over one week, +0.9% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Lucid Diagnostics Inc (LUCD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings 79/100 classification
One-week reaction 12.4% Price confirming higher
Trend fit Trend inactive 0.9% over four weeks
Fair value -5.0% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 10
Neutral 50
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 51
Industry context 13
Sector context 0

Sources

Coverage mix

Publishers
Market source 14
Stock Titan 11
TradingView 4
PR Newswire 4
MSN 3
StockStory 3
TradingKey 2
The Globe and Mail 2

Event Lens

What the news is about

Classified themes
Earnings 37
Market update 19
Analyst action 3
Deals and strategy 2
Capital return 1
Regulatory and legal 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 64
Stock Titan Direct company coverage

Lucid Diagnostics (NASDAQ: LUCD) seeks big share increase in 2026 proxy

Lucid Diagnostics (NASDAQ: LUCD) has filed a proxy statement for its June 24, 2026, annual meeting, seeking stockholder approval to increase authorized common shares from 300 million to 400 million. This increase aims to support future financings, equity awards, and conversions,

Tone
Neutral 50/100
Event
Regulatory and legal
Published
30 Apr 2026 21:10
Source
Stock Titan
MSN Direct company coverage

Lucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIG

BTIG reiterated its Buy rating on Lucid Diagnostics (LUCD) as the company is close to securing Medicare coverage for its EsoGuard test. CMS has established a new G-code for esophageal cellular সংগ্রহ tests, which may accelerate the approval process for EsoGuard.

Tone
Positive 92/100
Event
Analyst action
Published
27 Apr 2026 03:41
Source
MSN
Stock Titan Direct company coverage

Lucid Diagnostics (LUCD) CMO reports 650K restricted shares and 100K options

Lucid Diagnostics Chief Medical Officer, Victoria Lee Tou-ho, has filed an amended Form 3, disclosing her equity holdings. The report details 650,000 restricted shares of Common Stock with varying vesting dates through May 2029, dependent on service requirements. Additionally, sh

Tone
Neutral 50/100
Event
Market update
Published
24 Apr 2026 21:15
Source
Stock Titan
Stock Titan Direct company coverage

Lucid Diagnostics (NASDAQ: LUCD) closes $18M underwritten stock sale

Lucid Diagnostics Inc. (NASDAQ: LUCD) has announced the closing of an underwritten public offering, generating approximately $18 million in gross proceeds from the sale of 18,000,000 shares of common stock at $1.00 per share. The net proceeds, estimated at $16.8 million, will be

Tone
Positive 66/100
Event
Market update
Published
24 Apr 2026 20:39
Source
Stock Titan
TradingView Direct company coverage

Lucid Diagnostics closes $18M underwritten offering, issues 18M shares at $1.00

Lucid Diagnostics (LUCD) successfully closed an underwritten offering, selling 18 million common shares at $1.00 each to raise approximately $18 million in gross proceeds. Net proceeds of about $16.8 million are earmarked for working capital and general corporate purposes. The of

Tone
Positive 70/100
Event
Market update
Published
24 Apr 2026 20:09
Source
TradingView